Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
EWTX•Quarterly operating results
Aug. 6 (Reuters) - Edgewise Therapeutics Q2 operating expenses USD 61.943 million.
- Q2 net income USD -57.327 million
- Q2 basic EPS USD -0.53
EWTX•Aug. 6 (Reuters) - Edgewise Therapeutics Q2 operating expenses USD 61.943 million.